(Q53433076)

14 May 2018

title

Circulating tumour cells in peripheral blood: potential impact on breast cancer outcome. (English)

1 reference

14 May 2018

José Antonio Lorente

2

0 references

author name string

María José Serrano

1

1 reference

14 May 2018

Miguel Delgado Rodríguez

3

1 reference

14 May 2018

Ana Fernández

4

1 reference

14 May 2018

Mónica Fernández

5

1 reference

14 May 2018

Capilla de la Torre

6

1 reference

14 May 2018

Jaime Fernández Izquierdo

7

1 reference

14 May 2018

Pedro Sánchez Rovira

8

1 reference

14 May 2018

publication date

1 March 2011

1 reference

14 May 2018

Clinical and Translational Oncology

published in

1 reference

14 May 2018

volume

13

1 reference

14 May 2018

issue

3

1 reference

14 May 2018

page(s)

204-208

1 reference

14 May 2018

https://scigraph.springernature.com/pub.10.1007/s12094-011-0641-x

exact match

0 references

cites work

A pooled analysis of bone marrow micrometastasis in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0641-X

Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0641-X

Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0641-X

Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0641-X

HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0641-X

Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0641-X

Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0641-X

Review: Biological relevance of disseminated tumor cells in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0641-X

Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0641-X

Isolation of rare circulating tumour cells in cancer patients by microchip technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0641-X

Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0641-X

Circulating tumour cells in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0641-X

Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0641-X

Circulating tumor cells in breast cancer: methodology and clinical repercussions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0641-X

Molecular signature detection of circulating tumor cells using a panel of selected genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0641-X

Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0641-X

Prognostic significance of Ki-67 and topoisomerase IIalpha expression in infiltrating ductal carcinoma of the breast. A multivariate analysis of 863 cases

21 January 2018

1 reference

12 December 2020

Measuring circulating tumor cells as a surrogate end point for adjuvant therapy of breast cancer: what do they mean and what should we do about them?

1 reference

12 December 2020

Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival

1 reference

12 December 2020

Detection and clinical implications of early systemic tumor cell dissemination in breast cancer.

1 reference

12 December 2020

Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies

1 reference

12 December 2020

Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer

1 reference

12 December 2020

Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer

1 reference

12 December 2020

Detection of circulating tumor cells in the context of treatment: prognostic value in breast cancer

1 reference

12 December 2020

Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients

1 reference

12 December 2020

Bi-specific immunomagnetic enrichment of micrometastatic tumour cell clusters from bone marrow of cancer patients

1 reference

12 December 2020

Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden

1 reference

12 December 2020

10.1007/S12094-011-0641-X

Identifiers

DOI

1 reference

14 May 2018

1 reference

14 May 2018